New Multidisciplinary Center for Lung Disease To Open in North Haven yale.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yale.edu Daily Mail and Mail on Sunday newspapers.
March 15, 2021
by Jane E. Dee
The Winchester Center for Lung Disease, (WCLD), a multidisciplinary center for the diagnosis and care of patients with lung disease, opens in North Haven Medical Center on March 30, 2021. Located at 6 Devine Street, WCLD replaces the Winchester Chest Clinic. The center is a joint partnership with Yale New Haven Hospital, Yale Medicine, and Yale School of Medicine’s Section of Pulmonary, Critical Care & Sleep Medicine (Yale-PCCSM).
The state-of-the-art facility has 30 exam, consultation, and procedure rooms, and access to nearby laboratory services and multi-modality imaging. It will more than triple the clinical capacity of Yale-PCCSM’s practice, increasing the access patients with pulmonary symptoms and diseases have to Yale’s nationally renowned lung experts.
COVID-19: 5 blood proteins predict critical illness and death
Written by James Kingsland on March 3, 2021 Fact checked by Catherine Carver, MPH
Five key proteins in a person’s blood may predict their risk of developing severe COVID-19. Thana Prasongsin/Getty Images
A study suggests that among people hospitalized for COVID-19, blood levels of five proteins are higher in those who will go on to require critical care.
These proteins are associated with a type of immune cell that may promote excessive inflammation and blood clotting in the lungs.
Some of the same proteins are at elevated levels in people with obesity.
Study reveals blood tests can offer early indicator of severe COVID-19 ANI | Updated: Mar 02, 2021 09:44 IST
Washington [US], March 2 (ANI): A recent study has found that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19patients.
The findings of the study were published in the journal Blood Advances .
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. However, this study focuses on biomarkers that can help predict severe outcomes in COVID-19patients.
Read Time:
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery.
New Yale research could help them identify important early clues. In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients. Patients with high levels of these markers were much more like to require care in the intensive care unit, require ventilation, or die due to their COVID-19, said Dr. Hyung Chun, the lead author, an associate professor of medicine in cardiovascular medicine and pathology and director of translational research at the Yale Pulmonary Vascular Disease Program.